• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew Combs

Location
C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Summary
The estimated net worth of Andrew Combs is at least $332K dollars as of March 27, 2025. Andrew Combs is the Chief Chemistry Officer of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $332K.
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Andrew Combs files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Andrew Combs

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRLD Prelude Therapeutics Inc Chief Chemistry Officer $332K +$155K +87.1% Mar 25, 2025

Insider Transactions Reported by Andrew Combs:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.